Skip Navigation Bar
NLM logo

Unified Medical Language System® (UMLS®)

2010AA FDA Structured Product Labels Source Information

Counts

 (skip to: notes  samples)

Relationship Relationship Attribute Count (MRREL.RRF)
RO has_ingredient 29618
RO included_in 205

Notes

Sample data are taken from MRREL.RRF. Associated strings(str) from MRCONSO.RRF are also included

  • See relationships definitions below.
  • Every relationship has a separate row in MRREL.RRF.
  • Relationships are assigned based on source documentation or NLM understanding of the source.
  • Metathesaurus relationships in MRREL.RRF are read from right to left.
  • All relationships in MRREL.RRF are expressed in both directions, for example: 'has_ingredient/ingredient_of'. Inverse relationships in each pair are indicated on this page.
  • An asterisk (*) in the relationship attribute column indicates that no relationship attribute (RELA) was assigned.
  • Every even row (indicated by orange colored rel/rela pairs) indicates that the current row is an inverse relationship of the row above it.
  • See section 2.7.1.3.9 in UMLS Documentation Section 2, Metathesaurus for more information on Related Concepts, MRREL.RRF.

Relationship Definitions

  • AQ: allowed qualifier
  • CHD: has child (narrower hierarchical term)
  • DEL: deleted concept
  • PAR: has parent (broader hierarchical term)
  • QB: can be qualifier by
  • RB: has a broader relationship
  • RL: has similar or like relationship
  • RN: has narrower relationship
  • RO: has relationship other than synonymous, narrower or broader
  • RQ: related and possibly synonymous
  • SIB: has sibling
  • SY: source-asserted synonymy

Sample Data

RO

  (return to top)
CUI1 AUI1 STYPE1 STR REL RELA STR STYPE2 AUI2 CUI2
C0020268 A11567821 AUI Hydrocortisone RO has_ingredient Hydrocortisone 20 MILLIGRAM In 1 TABLET ORAL TABLET AUI A16033189 C0689115
C0689115 A16033189 AUI Hydrocortisone 20 MILLIGRAM In 1 TABLET ORAL TABLET RO ingredient_of Hydrocortisone AUI A11567821 C0020268
C0039468 A11772545 AUI temazepam RO has_ingredient temazepam 30 mg ORAL CAPSULE AUI A17114760 C0690438
C0690438 A17114760 AUI temazepam 30 mg ORAL CAPSULE RO ingredient_of temazepam AUI A11772545 C0039468
C0061851 A17041822 AUI ONDANSETRON RO has_ingredient ONDANSETRON 8 mg ORAL TABLET, ORALLY DISINTEGRATING AUI A17120788 C0979119
C0979119 A17120788 AUI ONDANSETRON 8 mg ORAL TABLET, ORALLY DISINTEGRATING RO ingredient_of ONDANSETRON AUI A17041822 C0061851
C1165801 A17042595 AUI SACCHAROMYCES CEREVISIAE RO has_ingredient SACCHAROMYCES CEREVISIAE 0.05 g in 1 mL INTRADERMAL INJECTION, SOLUTION AUI A17133750 C2728146
C2728146 A17133750 AUI SACCHAROMYCES CEREVISIAE 0.05 g in 1 mL INTRADERMAL INJECTION, SOLUTION RO ingredient_of SACCHAROMYCES CEREVISIAE AUI A17042595 C1165801
C2740668 A17113846 AUI BLACK-EYED PEA RO has_ingredient BLACK-EYED PEA 0.05 g in 1 mL INTRADERMAL INJECTION, SOLUTION AUI A17117431 C2728082
C2728082 A17117431 AUI BLACK-EYED PEA 0.05 g in 1 mL INTRADERMAL INJECTION, SOLUTION RO ingredient_of BLACK-EYED PEA AUI A17113846 C2740668
C2726149 A17125087 AUI FRAXINUS LATIFOLIA POLLEN RO has_ingredient FRAXINUS LATIFOLIA POLLEN 20000 [PNU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION AUI A17117068 C2727286
C2727286 A17117068 AUI FRAXINUS LATIFOLIA POLLEN 20000 [PNU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION RO ingredient_of FRAXINUS LATIFOLIA POLLEN AUI A17125087 C2726149
C0546879 A11569843 AUI tetracycline hydrochloride RO has_ingredient tetracycline hydrochloride 250 MILLIGRAM In 1 CAPSULE ORAL CAPSULE AUI A11568982 C0690469
C0690469 A11568982 AUI tetracycline hydrochloride 250 MILLIGRAM In 1 CAPSULE ORAL CAPSULE RO ingredient_of tetracycline hydrochloride AUI A11569843 C0546879
C0001714 A11569827 AUI polymyxin B sulfate RO has_ingredient neomycin sulfate 3.5 MILLIGRAM In 1 GRAM / polymyxin B sulfate 5000 UNITS In 1 GRAM / bacitracin zinc 400 UNITS In 1 GRAM / hydrocortisone 10 MILLIGRAM In 1 GRAM TOPICAL OINTMENT [Cortisporin] AUI A11771753 C1585568
C1585568 A11771753 AUI neomycin sulfate 3.5 MILLIGRAM In 1 GRAM / polymyxin B sulfate 5000 UNITS In 1 GRAM / bacitracin zinc 400 UNITS In 1 GRAM / hydrocortisone 10 MILLIGRAM In 1 GRAM TOPICAL OINTMENT [Cortisporin] RO ingredient_of polymyxin B sulfate AUI A11569827 C0001714
C0029997 A11769956 AUI Oxazepam RO has_ingredient Oxazepam 15 MILLIGRAM In 1 CAPSULE ORAL CAPSULE AUI A11767802 C0979176
C0979176 A11767802 AUI Oxazepam 15 MILLIGRAM In 1 CAPSULE ORAL CAPSULE RO ingredient_of Oxazepam AUI A11769956 C0029997

RO

  (return to top)
CUI1 AUI1 STYPE1 STR REL RELA STR STYPE2 AUI2 CUI2
C2370844 A11576937 AUI Lorazepam 2 MILLIGRAM In 1 MILLILITER INTRAMUSCULAR INJECTION, SOLUTION RO included_in Lorazepam 2 MILLIGRAM In 1 MILLILITER INTRAMUSCULAR INJECTION, SOLUTION_#2 AUI A16389659 C0978252
C0978252 A16389659 AUI Lorazepam 2 MILLIGRAM In 1 MILLILITER INTRAMUSCULAR INJECTION, SOLUTION_#2 RO includes Lorazepam 2 MILLIGRAM In 1 MILLILITER INTRAMUSCULAR INJECTION, SOLUTION AUI A11576937 C2370844
C2718182 A15524076 AUI prednisone 5 MILLIGRAM In 1 TABLET ORAL TABLET [Prednisone] RO included_in prednisone 5 MILLIGRAM In 1 TABLET ORAL TABLET [Prednisone]_#3 AUI A16487897 C0690124
C0690124 A16487897 AUI prednisone 5 MILLIGRAM In 1 TABLET ORAL TABLET [Prednisone]_#3 RO includes prednisone 5 MILLIGRAM In 1 TABLET ORAL TABLET [Prednisone] AUI A15524076 C2718182
C2723795 A17041464 AUI FLUTICASONE PROPIONATE 50 ug RESPIRATORY (INHALATION) POWDER, METERED [FLOVENTDISKUS] RO included_in FLUTICASONE PROPIONATE 50 ug RESPIRATORY (INHALATION) POWDER, METERED [FLOVENTDISKUS]_#2 AUI A17038755 C1966484
C1966484 A17038755 AUI FLUTICASONE PROPIONATE 50 ug RESPIRATORY (INHALATION) POWDER, METERED [FLOVENTDISKUS]_#2 RO includes FLUTICASONE PROPIONATE 50 ug RESPIRATORY (INHALATION) POWDER, METERED [FLOVENTDISKUS] AUI A17041464 C2723795
C2725982 A17113774 AUI HEPATITIS A VIRUS STRAIN HM175 ANTIGEN (FORMALDEHYDE INACTIVATED) 720 [iU] in 1 mL / HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 20 ug in 1 mL INTRAMUSCULAR INJECTION, SUSPENSION [TWINRIX] RO included_in HEPATITIS A VIRUS STRAIN HM175 ANTIGEN (FORMALDEHYDE INACTIVATED) 720 [iU] in 1 mL / HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 20 ug in 1 mL INTRAMUSCULAR INJECTION, SUSPENSION [TWINRIX]_#2 AUI A17132786 C2344119
C2344119 A17132786 AUI HEPATITIS A VIRUS STRAIN HM175 ANTIGEN (FORMALDEHYDE INACTIVATED) 720 [iU] in 1 mL / HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 20 ug in 1 mL INTRAMUSCULAR INJECTION, SUSPENSION [TWINRIX]_#2 RO includes HEPATITIS A VIRUS STRAIN HM175 ANTIGEN (FORMALDEHYDE INACTIVATED) 720 [iU] in 1 mL / HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 20 ug in 1 mL INTRAMUSCULAR INJECTION, SUSPENSION [TWINRIX] AUI A17113774 C2725982
C2725980 A17116571 AUI HEPATITIS A VIRUS STRAIN HM175 ANTIGEN (FORMALDEHYDE INACTIVATED) 1440 [iU] in 1 mL INTRAMUSCULAR INJECTION, SUSPENSION [HAVRIX] RO included_in HEPATITIS A VIRUS STRAIN HM175 ANTIGEN (FORMALDEHYDE INACTIVATED) 1440 [iU] in 1 mL INTRAMUSCULAR INJECTION, SUSPENSION [HAVRIX]_#2 AUI A17118524 C1322283
C1322283 A17118524 AUI HEPATITIS A VIRUS STRAIN HM175 ANTIGEN (FORMALDEHYDE INACTIVATED) 1440 [iU] in 1 mL INTRAMUSCULAR INJECTION, SUSPENSION [HAVRIX]_#2 RO includes HEPATITIS A VIRUS STRAIN HM175 ANTIGEN (FORMALDEHYDE INACTIVATED) 1440 [iU] in 1 mL INTRAMUSCULAR INJECTION, SUSPENSION [HAVRIX] AUI A17116571 C2725980
C2720521 A17130384 AUI risedronate sodium 35 mg ORAL TABLET, FILM COATED [Actonel] RO included_in risedronate sodium 35 mg ORAL TABLET, FILM COATED [Actonel]_#2 AUI A17121817 C1576925
C1576925 A17121817 AUI risedronate sodium 35 mg ORAL TABLET, FILM COATED [Actonel]_#2 RO includes risedronate sodium 35 mg ORAL TABLET, FILM COATED [Actonel] AUI A17130384 C2720521
C2731995 A17286440 AUI Monoclate-P KIT RO included_in Monoclate-P KIT_#1 AUI A17295781 C2343028
C2343028 A17295781 AUI Monoclate-P KIT_#1 RO includes Monoclate-P KIT AUI A17286440 C2731995
C1813224 A17027079 AUI FLUTICASONE PROPIONATE 115 ug / SALMETEROL XINAFOATE 21 ug RESPIRATORY (INHALATION) AEROSOL, METERED [ADVAIR HFA] RO included_in FLUTICASONE PROPIONATE 115 ug / SALMETEROL XINAFOATE 21 ug RESPIRATORY (INHALATION) AEROSOL, METERED [ADVAIR HFA]_#2 AUI A17384321 C2731901
C2731901 A17384321 AUI FLUTICASONE PROPIONATE 115 ug / SALMETEROL XINAFOATE 21 ug RESPIRATORY (INHALATION) AEROSOL, METERED [ADVAIR HFA]_#2 RO includes FLUTICASONE PROPIONATE 115 ug / SALMETEROL XINAFOATE 21 ug RESPIRATORY (INHALATION) AEROSOL, METERED [ADVAIR HFA] AUI A17027079 C1813224
C2343270 A17386859 AUI regadenoson 0.08 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION [Lexiscan] RO included_in regadenoson 0.08 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION [Lexiscan]_#2 AUI A17388879 C2343280
C2343280 A17388879 AUI regadenoson 0.08 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION [Lexiscan]_#2 RO includes regadenoson 0.08 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION [Lexiscan] AUI A17386859 C2343270

Last Reviewed: June 4, 2010